Plavix - 55154-2022-0 - (clopidogrel bisulfate)

Alphabetical Index


Drug Information of Plavix

Product NDC: 55154-2022
Proprietary Name: Plavix
Non Proprietary Name: clopidogrel bisulfate
Active Ingredient(s): 300    mg/1 & nbsp;   clopidogrel bisulfate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Plavix

Product NDC: 55154-2022
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020839
Marketing Category: NDA
Start Marketing Date: 19971117

Package Information of Plavix

Package NDC: 55154-2022-0
Package Description: 10 BLISTER PACK in 1 BAG (55154-2022-0) > 1 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of Plavix

NDC Code 55154-2022-0
Proprietary Name Plavix
Package Description 10 BLISTER PACK in 1 BAG (55154-2022-0) > 1 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 55154-2022
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name clopidogrel bisulfate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19971117
Marketing Category Name NDA
Labeler Name Cardinal Health
Substance Name CLOPIDOGREL BISULFATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]

Complete Information of Plavix


General Information